HIF-1α-induced β-catenin activation prevents prion-mediated neurotoxicity

International Journal of Molecular Medicine

Volumn 32, Issue 4, 2013, Pages 931-937

  Jeong, Jae Kyo ^a   Park, Sang Youel ^a  

^a Chonbuk National University   (South Korea)

Author keywords

catenin; Hypoxia; Hypoxia inducible factor 1 ; Mitochondrial dysfunction; Prion diseases

Indexed keywords

BETA CATENIN; CASPASE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ICG 001; NEUROPROTECTIVE AGENT; PRION PROTEIN; PROTEIN BCL 2; PROTEIN INHIBITOR; PROTEIN P53; SURVIVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; BETA CATENIN; BICYCLO COMPOUNDS, HETEROCYCLIC; CELL HYPOXIA; CELL LINE, TUMOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IN SITU NICK-END LABELING; MELATONIN; NEURONS; PEPTIDE FRAGMENTS; PRION DISEASES; PRIONS; PYRIMIDINONES; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84883364390     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1457     Document Type: Article

References (38)

1. Prusiner SB: Prions. Proc Natl Acad Sci USA 95: 13363-13383, 1998.
2. Wickner RB: Prion diseases: Infectivity versus toxicity. Nature 470: 470-471, 2011.
3. Eghiaian F, Grosclaude J, Lesceu S, et al: Insight into the PrPC-PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants. Proc Natl Acad Sci USA 101: 10254-10259, 2004.
4. Turnbaugh JA, Unterberger U, Saá P, et al: The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc). J Neurosci 32: 8817-8830, 2012.
5. Sim VL and Caughey B: Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol Aging 30: 2031-2042, 2009.
6. Jeong JK, Moon MH, Bae BC, et al: Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity. Neurosci Res 73: 99-105, 2012.
7. Jeong JK, Moon MH, Lee YJ, Seol JW and Park SY: Autophagy induced by the class III histone deacetylase Sirt1 prevents prion peptide neurotoxicity. Neurobiol Aging 34: 146-156, 2013.
8. Aiken JM, Williamson JL and Marsh RF: Evidence of mitochondrial involvement in scrapie infection. J Virol 63: 1686-1694, 1989.
9. Quintanilla RA, Dolan PJ, Jin YN and Johnson GV: Truncated tau and A? cooperatively impair mitochondria in primary neurons. Neurobiol Aging 33: 619.e25-35, 2012.
10. Freixes M, Rodriguez A, Dalfo E and Ferrer I: Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol Aging 27: 1807-1815, 2006.
11. Jeong JK, Moon MH, Park YG, et al: Gingerol-induced hypoxia-inducible factor 1 alpha inhibits human prion peptide-mediated neurotoxicity. Phytother Res 27: 1185-1192, 2013.
12. Xie L, Johnson RS and Freeman RS: Inhibition of NGF deprivation-induced death by low oxygen involves suppression of BIMEL and activation of HIF-1. J Cell Biol 168: 911-920, 2005.
13. Strey CW, Gestrich J, Beckhaus T, et al: Hypoxia and reoxygenation of primary human hepatocytes induce proteome changes of glucose metabolism, oxidative protection and peroxisomal function. Int J Mol Med 26: 577-584, 2010.
14. Selvendiran K, Bratasz A, Kuppusamy ML, Tazi MF, Rivera BK and Kuppusamy P: Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. Int J Cancer 125: 2198-2204, 2009.
15. Gardner LB and Corn PG: Hypoxic regulation of mRNA expression. Cell Cycle 7: 1916-1924, 2008.
16. Malik A, Korol A, Weber M, Hankeln T, Avivi A and Band M: Transcriptome analysis of the spalax hypoxia survival response includes suppression of apoptosis and tight control of angiogenesis. BMC Genomics 13: 615, 2012.
17. Ryan HE, Lo J and Johnson RS: HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17: 3005-3015, 1998.
18. Lee SH, Koo KH, Park JW, et al: HIF-1 is induced via EGFR activation and mediates resistance to anoikis-like cell death under lipid rafts/caveolae- disrupting stress. Carcinogenesis 30: 1997-2004, 2009.
19. Adams JM, Difazio LT, Rolandelli RH, et al: HIF-1: a key mediator in hypoxia. Acta Physiol Hung 96: 19-28, 2009.
20. Koh MY, Spivak-Kroizman TR and Powis G: HIF-1alpha and cancer therapy. Recent Results Cancer Res 180: 15-34, 2010.
21. Ke Q and Costa M: Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70: 1469-1480, 2006.
22. Jeong JK, Seo JS, Moon MH, Lee YJ, Seol JW and Park SY: Hypoxia-inducible factor-1? regulates prion protein expression to protect against neuron cell damage. Neurobiol Aging 33: 1006.e1-10, 2012.
23. Singh N, Sharma G and Mishra V: Hypoxia inducible factor-1: its potential role in cerebral ischemia. Cell Mol Neurobiol 32: 491-507, 2012.
24. Seo JS, Seol JW, Moon MH, Jeong JK, Lee YJ and Park SY: Hypoxia protects neuronal cells from human prion protein fragment-induced apoptosis. J Neurochem 112: 715-722, 2010.
25. Zhang Q, Qian Z, Pan L, Li H and Zhu H: Hypoxia-inducible factor 1 mediates the anti-apoptosis of berberine in neurons during hypoxia/ischemia. Acta Physiol Hung 99: 311-323, 2012.
26. Cunningham LA, Candelario K and Li L: Roles for HIF-1? in neural stem cell function and the regenerative response to stroke. Behav Brain Res 227: 410-417, 2012.
27. Lehwald N, Tao GZ, Jang KY, et al: ?-Catenin regulates hepatic mitochondrial function and energy balance in mice. Gastroenterology 143: 754-764, 2012.
28. Flaherty MP, Kamerzell TJ and Dawn B: Wnt signaling and cardiac differentiation. Prog Mol Biol Transl Sci 111: 153-174, 2012.
29. Wiedau-Pazos M, Wong E, Solomon E, Alarcon M and Geschwind DH: Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 mice. Neurobiol Aging 30: 14-21, 2009.
30. Meyers J, Hu L, Moses A, Kaboli K, Papandrea A and Raymond P: ?-catenin/Wnt signaling controls progenitor fate in the developing and regenerating zebrafish retina. Neural Dev 7: 30, 2012.
31. Mazumdar J, O'Brien WT, Johnson RS, et al: O2 regulates stem cells through Wnt/?-catenin signalling. Nat Cell Biol 12: 1007-1013, 2010.
32. Wei L, Sun C, Lei M, et al: Activation of Wnt/?-catenin pathway by exogenous Wnt1 protects SH-SY5Y cells against 6-hydroxydopamine toxicity. J Mol Neurosci 49: 105-115, 2013.
33. Liu S, Yeh TH, Singh VP, et al: ?-Catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice. Hepatology 55: 931-940, 2012.
34. Mitani T, Harada N, Nakano Y, Inui H and Yamaji R: Coordinated action of hypoxia-inducible factor-1 and catenin in androgen receptor signaling. J Biol Chem 287: 33594-33606, 2012.
35. Jeong JK, Moon MH, Seo JS, Seol JW, Park SY and Lee YJ: Hypoxia inducing factor-1alpha regulates tumor necrosis factor-related apoptosis-inducing ligand sensitivity in tumor cells exposed to hypoxia. Biochem Biophys Res Commun 399: 379-383, 2010.
36. L'Episcopo F, Tirolo C, Testa N, et al: Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/?-catenin signaling pathways: functional consequences for neuroprotection and repair. J Neurosci 32: 2062-2085, 2012.
37. Liang J, Liu L and Xing D: Photobiomodulation by low-power laser irradiation attenuates A?-induced cell apoptosis through the Akt/GSK3?/?-catenin pathway. Free Radic Biol Med 53: 1459-1467, 2012.
38. Hota KB, Hota SK, Srivastava RB and Singh SB: Neuroglobin regulates hypoxic response of neuronal cells through Hif-1?- and Nrf2-mediated mechanism. J Cereb Blood Flow Metab 32: 1046-1060, 2012.